Dramatic co-activation of WWOX/WOX1 with CREB and NF-κB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Li, Meng Yen ^a   Lai, Feng Jie ^b   Hsu, Li Jin ^a   Lo, Chen Peng ^a   Cheng, Ching Li ^a   Lin, Sing Ru ^a   Lee, Ming Hui ^a   Chang, Jean Yun ^a   Subhan, Dudekula ^a   Tsai, Ming Shu ^c   Sze, Chun I ^a   Pugazhenthi, Subbiah ^d   Chang, Nan Shan ^a,e   Chen, Shur Tzu ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Executive Yuan   (Taiwan)

^d UNIVERSITY OF COLORADO   (United States)

^e State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN C JUN; PROTEIN P53; SMAD3 PROTEIN; TRANSCRIPTION FACTOR ELK 1; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR WOX1; TUMOR SUPPRESSOR WW DOMAIN CONTAINING OXIDOREDUCTASE; UNCLASSIFIED DRUG; CREB1 PROTEIN, RAT; OXIDOREDUCTASE; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL NECROSIS; NERVE INJURY; NONHUMAN; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SCIATIC NERVE; SPINAL GANGLION; UPREGULATION; ANIMAL; MALE; METABOLISM; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; GANGLIA, SPINAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 8; NEURONS; NF-KAPPA B; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 70649087176     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007820     Document Type: Article

References (53)

1. Sze CI, Su M, Pugazhenthi S, Jambal P, Hsu LJ, et al. (2004) Downregulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro: A potential role in Alzheimer's disease. J Biol Chem 279: 30498-30506.
2. Chen ST, Chuang JI, Cheng CL, Hsu LJ, Chang NS (2005) Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translation of WW domain-containing oxidoreductase in vivo. Neuroscience 130: 397-407.
3. Lo CP, Hsu LJ, Li MY, Hsu SY, Chuang JI, et al. (2008) MPP+-Induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1. Eur J Neurosci 27: 1634-1646.
4. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, et al. (2000) WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 60: 2140-2145.
5. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, et al. (2000) Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9: 1651-1663.
6. Chang NS, Pratt N, Heath J, Schultz L, Sleve D, et al. (2001) Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem 276: 3361-3370.
7. Chang NS, Doherty J, Ensign A, Schultz L, Hsu LJ, et al. (2005) WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46- phosphorylated p53. J Biol Chem 280: 43100-43108.
8. Chang NS, Schultz L, Hsu LJ, Lewis J, Su M, et al. (2005) 17β-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene 24: 714-723.
9. Mahajan NP, Whang YE, Mohler JL, Earp HS (2005) Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res 65: 10514-10523.
10. Chang NS, Hsu LJ, Lin YS, Lai FJ, Sheu HM (2007) WW domain-containing oxidoreductase: a candidate tumor suppressor. Trends Mol Med 13: 12-22.
11. Smith DI, McAvoy S, Zhu Y, Perez DS (2007) Large common fragile site genes and cancer. Semin Cancer Biol 17: 31-41.
12. Aqeilan RI, Croce CM (2007) WWOX in biological control and tumorigenesis. J Cell Physiol 212: 307-310.
13. Chang NS, Doherty J, Ensign A (2003) JNK1 physically interacts with WW domain- containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem 278: 9195-9202.
14. Lai FJ, Cheng CL, Chen ST, Wu CH, Hsu LJ, et al. (2005) WOX1 is essential for UVB irradiation-induced apoptosis and down-regulation via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo. Clin Cancer Res 11: 5769-5777.
15. Aderca I, Moser CD, Veerasamy M, Bani-Hani AH, Bonilla-Guerrero R, et al. (2008) The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. J Hepatol 49: 373-383.
16. Chen ST, Chuang JI, Wang JP, Tsai MS, Li H, et al. (2004) Expression of WW domain-containing oxidoreductase WOX1 in developing murine nervous system. Neuroscience 124: 831-839.
17. Herdegen T, Leah JD (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28: 370-490.
18. Raivich G, Behrens A (2006) Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog Neurobiol 78: 347-363.
19. Jenkins R, Hunt SP (1991) Long-term increase in the levels of c-jun mRNA and Jun protein-like immunoreactivity in motor and sensory neurons following axon damage. Neurosci Lett 129: 107-111.
20. Broude E, McAtee M, Kelley MS, Bregman BS (1997) c-Jun expression in adult rat dorsal root ganglion neurons: differential response after central or peripheral axotomy. Exp Neurol 148: 367-377.
21. Kenney AM, Kocsis JD (1997) Temporal variability of jun family transcription factor levels in peripherally or centrally transected adult rat dorsal root ganglia. Brain Res Mol Brain Res 52: 53-61.
22. De Felipe C, Hunt SP (1994) The differential control of c-Jun expression in regenerating sensory neurons and their associated glial cells. J Neurosci 14: 2911-2923.
23. Raivich G, Bohatschek M, Da Costa C, Iwata O, Galiano M, et al. (2004) The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43: 57-67.
24. Soares HD, Chen SC, Morgan JI (2001) Differential and prolonged expression of Fos-lacZ and Jun-lacZ in neurons, glia, and muscle following sciatic nerve damage. Exp Neurol 167: 1-14.
25. Son SJ, Lee KM, Jeon SM, Park ES, Park KM, et al. (2007) Activation of transcription factor c-jun in dorsal root ganglia induces VIP and NPY upregulation and contributes to the pathogenesis of neuropathic pain. Exp Neurol 204: 467-472.
26. Qiao LY, Vizzard MA (2005) Spinal cord injury-induced expression of TrkA, TrkB, phosphorylated CREB, and c-Jun in rat lumbosacral dorsal root ganglia. J Comp Neurol 482: 142-154.
27. Tandrup T, Woolf CJ, Coggeshall RE (2000) Delayed loss of small dorsal root ganglion cells after transection of the rat sciatic nerve. J Comp Neurobiol 422: 172-180.
28. Yi JH, Park SW, Kapadia R, Vemuganti R (2007) Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int 50: 1014-1027.
29. Alavian KN, Scholz C, Simon HH (2008) Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Mov Disord 23: 319-328.
30. Hsu LJ, Schultz L, Hong Q, Van Moer K, Heath J, et al. (2009) Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1. J Biol Chem 284: 16049-16059.
31. Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, et al. (1999) Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway. J Biol Chem 274: 2829-2837.
32. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, et al. (2000) Akt/Protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766.
33. Ham J, Eilers A, Whitfield J, Neame SJ, Shah B (2000) c-Jun and the transcriptional control of neuronal apoptosis. Biochem Pharmacol 60: 1015-1021.
34. Demir O, Aksan Kurnaz I (2008) Wildtype Elk-1, but not a SUMOylation mutant, represses egr-1 expression in SH-SY5Y neuroblastomas. Neurosci Lett 437: 20-24.
35. Zhong S, Fromm J, Johnson DL (2007) TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Mol Cell Biol 27: 54-64.
36. Shao N, Chai Y, Cui JQ, Wang N, Aysola K, et al. (1998) Induction of apoptosis by Elk-1 and deltaElk-1 proteins. Oncogene 17: 527-532.
37. Barrett LE, Sul JY, Takano H, Van Bockstaele EJ, Haydon PG, et al. (2006) Region-directed phototransfection reveals the functional significance of a dendritically synthesized transcription factor. Nat Methods 3: 455-460.
38. Chang YC, Huang CC (2006) Perinatal brain injury and regulation of transcription. Curr Opin Neurol 19: 141-147.
39. Kitagawa K (2007) CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J 274: 3210-3217.
40. Sarkar SA, Kutlu B, Velmurugan K, Kizaka-Kondoh S, Lee CE, et al. (2009) Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 52: 1092-1101.
41. Bednarski BK, Baldwin AS Jr, Kim HJ (2009) Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin. PLoS One 4: e6992.
42. Gaudio E, Palamarchuk A, Palumbo T, Trapasso F, Pekarsky Y, et al. (2006) Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res 66: 11585-11589.
43. Buschmann T, Martin-Villalba A, Kocsis JD, Waxman SG, Zimmermann M, et al. (1998) Expression of Jun, Fos, and ATF-2 proteins in axotomized explanted and cultured adult rat dorsal root ganglia. Neuroscience 84: 163-176.
44. Barron KD (2004) The axotomy response. J Neurol Sci 220: 119-121.
45. Persengiev SP, Green MR (2003) The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 8: 225-228.
46. Hai T, Hartman MG (2001) The molecular biology and nomemclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1-11.
47. Lu D, Wolfgang CD, Hai T (2006) Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem 281: 10473-10481.
48. Hayakawa J, Depatie C, Ohmichi M, Mercola D (2003) The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem 278: 20582-20592.
49. Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35: 605-623.
50. Teng FY, Tang BL (2006) Axonal regeneration in adult CNS neurons-signaling molecules and pathways. J Neurochem 96: 1501-1508.
51. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, et al. (2006) A role for the WWOX gene in prostate cancer. Cancer Res 66: 6477-6481.
52. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan RI, Cimmino A, et al. (2005) WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci U S A 102: 15611-15616.
53. + in the rat. Neurochem Int 40: 169-179.